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Structured summary:
Objective and background Anemia and thyroid dysfunction are common and often co-occur. Current guidelines recommend the assessment of thyroid function in the work-up of anemia, although evidence on this association is scarce.
Patients and Methods
In the "European Prospective Investigation of Cancer" (EPIC)-Norfolk population-based cohort, we aimed to examine the prevalence and type of anemia (defined as hemoglobin <13 g/dl for men and <12 g/dl for women) according to different thyroid function groups.
Results
The mean age of the 8791 participants was 59.4 (SD 9.1) years and 55.2% were women.
Thyroid dysfunction was present in 437 (5.0%) and anemia in 517 (5.9%) participants. After excluding 121 participants with three most common causes of anemia (chronic kidney disease, inflammation, iron deficiency), anemia was found in 4.7% of euthyroid participants.
Compared with the euthyroid group, the prevalence of anemia was significantly higher in overt hyperthyroidism (14.6%, P < .01), higher with borderline significance in overt hypothyroidism (7.7%, P = .05) and not increased in subclinical thyroid dysfunction (5.0% in subclinical hypothyroidism, 3.3% in subclinical hyperthyroidism). Anemia associated with thyroid dysfunction was mainly normocytic (94.0%), and rarely macrocytic (6.0%).
Conclusion
The prevalence of anemia was higher in overt hyperthyroidism, but not increased in subclinical thyroid dysfunction. Systematic measurement of thyroid-stimulating hormone in anemic patients is likely to be useful only after excluding common causes of anemia.
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Introduction:
Anemia and thyroid dysfunction are common disorders that often co-occur in the elderly. 1, 2 More than 10% of patients aged ≥65 years have anemia 3 and the prevalence of subclinical thyroid dysfunction increases with age, with 15-20% of those above 60 years having subclinical hypothyroidism. [4] [5] Hypothyroidism may lead to anemia because of bone marrow repression and decrease in erythropoietin secretion, 6 while the relationship between hyperthyroidism and anemia is less clear. [7] [8] [9] [10] In a recent study, the prevalence of hypothyroidism in 316 hospitalized patients above 65 years was significantly higher in the presence of anemia (31 out of 155 patients) compared to their counterparts without anemia (16 out of 161; P = .01); 1 however, this study was limited by its small size, by the hospital setting, and did not differentiate between overt and subclinical hypothyroidism.
Furthermore, the relationship between thyroid dysfunction and the type of anemia (micro-, normo-or macrocytic) remains unclear. Hypothyroidism has been associated with macrocytosis, and even though this association seems uncommon and particularly related to severe hypothyroidism, TSH measurement is commonly recommended in the work-up of macrocytosis.
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Other studies showed that anemia due to thyroid dysfunction is more often normocytic than macrocytic. 6,15-17 Even though data on the association between thyroid dysfunction and anemia remain scarce, TSH measurement is still recommended in the initial work-up of anemia. 2, [11] [12] [13] [14] To fill this gap in knowledge, we examined the prevalence of anemia according to different thyroid function groups and assessed the type of anemia associated with thyroid dysfunction in a large population-based study.
Methods:
Patients and laboratory data using the MDRD equation, 24-25 while less conservative cut-offs were used in sensitivity analyses.
22,26
In the EPIC-Norfolk study, 8791 adults had TSH, ferritin, CRP and eGFR measurements and were available for this analysis.
Statistical analyses
We studied the prevalence of anemia in the overall sample and in five groups defined according to their thyroid status (euthyroid, OHypo, SHypo, SHyper, OHyper). We compared the prevalence of anemia between these groups using Fisher's exact tests of association.
We compared Hb concentration across the groups using age and sex adjusted quadratic pattern linear regression with robust standard errors.
Results and Discussion
Among the 8791 participants, the mean age was 59.4 (SD 9. and/or inflammatory disease. After excluding these participants, the proportion of 4.8% with anemia and overt thyroid dysfunction dropped to 3.1% (7/228, data not shown). In another sensitivity analysis with lower Hb cut-offs (<12 g/dl for men and <11 g/dl for women), the prevalence of anemia was 3.0% (263 out of 8699) and remained significantly higher in participants with OHyper only, compared to euthyroidism (10.4% versus 2.9%, P < .01). Anemia was normocytic in 94.0% and macrocytic in 6.0% of the participants with thyroid dysfunction, but never microcytic (Table 2 ).
In age and sex adjusted analyses, Hb concentration was lower in participants with both hyper-or hypothyroid dysfunction compared to the euthyroid state (P-value for quadratic pattern < .001). The only group which significantly differed from the euthyroid reference was
OHyper (Hb -0.49 g/dl; CI -0.93 to -0.05; P = .03), while the difference was borderline significant for OHypo (Hb -0.17 g/dl; CI -0.33 to -0.00; P = .05; Figure 1 ).
In this large population-based cohort, the prevalence of anemia was higher among adults with overt hyperthyroidism, borderline significantly higher in those with overt hypothyroidism, while it did not differ in those with subclinical thyroid dysfunction, compared to the euthyroid state. Although most guidelines recommend a systematic TSH measurement among patients with anemia, 2,11-14 screening for thyroid dysfunction leads to the identification of only 4.8%
(19/396) of adults with overt thyroid dysfunction after excluding three other common causes of anemia. This proportion might have been even further reduced by excluding participants with anemia due to vitamin B12 and/or folate deficiency, which were not assessed in the EPIC-Norfolk cohort and account for about 14% of causes of mainly macrocytic anemia in 6 other population-based studies. 20 A previous small study (n = 400) in ambulatory care found that the prevalence of anemia, after excluding other common etiologies, was significantly higher in patients with overt (43%, P = .0003) or subclinical (39%, P = .021) hypothyroidism when compared with healthy controls (23%). 6 Our results suggest a higher prevalence of anemia in participants with overt, but not in those with subclinical hypothyroidism. This partial discrepancy could be explained by the high prevalence of anemia (33% compared to ours at 5.9%), possibly due to different population characteristics and study design; this previous study was indeed not population-based and included 60-70% participants with anemia of chronic disease. The small prevalence of macrocytosis in our study is consistent with previous studies [10] [11] [12] [13] and further supports the fact that macrocytosis, although traditionally associated with hypothyroidism, is probably a rare finding in this population and rather relates to severe hypothyroidism.
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However, studies with larger number of participants with macrocytosis are warranted to confirm our findings.
Our study has some limitations. TSH was measured only once at baseline, which is a limitation of most previous cohorts on the risks associated with thyroid dysfunction 27-29 and we might have found a stronger relationship between subclinical thyroid dysfunction and anemia if we had studied only participants with persistent subclinical thyroid dysfunction. We did not measure vitamin B12 and folate; however, daily folate and vitamin B12 intakes were 200-350 µg 30 and 2-14 µg 31 respectively in the EPIC-Norfolk cohort, which fulfils the current nutritional recommendations for both vitamins.
31-32
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In conclusion, our data from the largest population-based study on this issue suggest that the prevalence of anemia is higher in overt hyperthyroidism and borderline statistically significant higher in overt hypothyroidism, but not increased in subclinical thyroid dysfunction. TSH measurement should not be routinely recommended in the initial work-up of anemia, but only after excluding other common causes, such as iron deficiency, chronic kidney disease, inflammatory disease, vitamin B12 and folate deficiency. Overt hyperthyroidism 41 7 (14.6) < .01
* 121 participants were excluded as they had iron deficiency (defined as ferritin <15 ng/ml, n = 56), inflammatory state (CRP ≥10 mg/l, n = 58), chronic kidney disease (estimated glomerular filtration rate ≤30 ml/min/1.73m 2 , n = 6), or both inflammatory state and chronic kidney disease (n = 1). In a sensitivity analysis using less conservative cut-offs for chronic kidney disease (eGFR <60 ml/min/1.73m 2 ), 22 and iron deficiency (ferritin <30 ng/ml), 18 289/517 participants had at least one of these three common causes. § P-value for the significance of the difference of prevalence of anemia in each thyroid function group compared to the euthyroid state (reference group). 
